SRAM
ABMD

Stone Ridge Asset Management’s Abiomed Inc ABMD Stock Holding History

Stone Ridge Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-9,636
Closed -$784K – 1227
2019
Q1 		$784K Buy
9,636
+7,296
+312% +$2.42M 0.04% 523
2018
Q4 		$761K Buy
+2,340
New +$813K 0.05% 557
2018
Q3 		– Sell
-12,000
Closed -$4.91M – 1321
2018
Q2 		$4.91M Buy
+12,000
New +$4.35M 0.28% 63

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Amundi Asset Management US
Amundi Asset Management US Boston, Massachusetts $131B AUM 73.57% 1-Year Est. Return

Stone Ridge Asset Management's ABMD Position: Q2 2019 in Review

Stone Ridge Asset Management sold out of Abiomed Inc (ABMD) in Q2 2019, closing a stake of 9,636 shares — an estimated $784K sold.

Stone Ridge Asset Management first reported a position in ABMD in Q2 2018 and held it in 3 quarters. The position peaked at $4.91M in Q2 2018. 484 funds tracked by Wall St. Rank hold ABMD as of Q2 2019.

  • Stone Ridge Asset Management reported no remaining Abiomed Inc position as of Q2 2019 after selling out during the quarter.
  • Stone Ridge Asset Management sold 9,636 Abiomed Inc shares in Q2 2019, an estimated $784K.
  • Stone Ridge Asset Management first reported a position in Abiomed Inc in Q2 2018 and held it in 3 quarters.
  • Stone Ridge Asset Management's Abiomed Inc position peaked at $4.91M in Q2 2018.
  • 484 funds tracked by Wall St. Rank held Abiomed Inc as of Q2 2019.

Based on Stone Ridge Asset Management's 13F filing for Q2 2019, filed 6 Aug 2019.